Christopher Holroyd

3.6k total citations · 1 hit paper
42 papers, 2.0k citations indexed

About

Christopher Holroyd is a scholar working on Rheumatology, Hematology and Orthopedics and Sports Medicine. According to data from OpenAlex, Christopher Holroyd has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Rheumatology, 7 papers in Hematology and 7 papers in Orthopedics and Sports Medicine. Recurrent topics in Christopher Holroyd's work include Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (7 papers) and Bone health and osteoporosis research (7 papers). Christopher Holroyd is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (7 papers) and Bone health and osteoporosis research (7 papers). Christopher Holroyd collaborates with scholars based in United Kingdom, United States and Belgium. Christopher Holroyd's co-authors include Cyrus Cooper, Elaine Dennison, Nicholas C. Harvey, Zoe Cole, Christopher J Edwards, John А. Kanis, S. R. Cummings, L. Joseph Melton, May Nwe Lwin and Keith M. Godfrey and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Bone and Mineral Research and Annals of the Rheumatic Diseases.

In The Last Decade

Christopher Holroyd

40 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Secular trends in the incidence of hip and other osteoporotic fractures

2011 692 citations Cyrus Cooper, Zoe Cole et al. Osteoporosis International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Holroyd United Kingdom	16	693	687	361	294	228	42	2.0k
Jordi Bover Spain	33	557 0.8×	649 0.9×	205 0.6×	657 2.2×	143 0.6×	164	3.5k
Juraj Payer Slovakia	20	482 0.7×	315 0.5×	425 1.2×	351 1.2×	294 1.3×	132	1.9k
Celia L. Gregson United Kingdom	25	1.3k 1.8×	967 1.4×	352 1.0×	255 0.9×	303 1.3×	134	2.9k
Jin‐Su Choi South Korea	29	384 0.6×	564 0.8×	319 0.9×	312 1.1×	456 2.0×	111	2.8k
H.G.M. Leufkens Netherlands	13	845 1.2×	810 1.2×	162 0.4×	138 0.5×	360 1.6×	29	2.0k
Michelle Denburg United States	29	259 0.4×	283 0.4×	197 0.5×	395 1.3×	253 1.1×	110	2.6k
Hans Peter Dimai Austria	24	1.2k 1.7×	684 1.0×	153 0.4×	649 2.2×	222 1.0×	93	2.5k
Joanne Homik Canada	22	527 0.8×	749 1.1×	597 1.7×	511 1.7×	121 0.5×	49	2.3k
Rafael Poveda Spain	25	366 0.5×	342 0.5×	295 0.8×	160 0.5×	264 1.2×	51	2.9k
P. Sambrook Australia	24	920 1.3×	373 0.5×	438 1.2×	335 1.1×	134 0.6×	41	2.0k

Countries citing papers authored by Christopher Holroyd

Since Specialization

Citations

This map shows the geographic impact of Christopher Holroyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Holroyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Holroyd more than expected).

Fields of papers citing papers by Christopher Holroyd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Holroyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Holroyd. The network helps show where Christopher Holroyd may publish in the future.

Co-authorship network of co-authors of Christopher Holroyd

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Holroyd. A scholar is included among the top collaborators of Christopher Holroyd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Holroyd. Christopher Holroyd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fraser, Simon, et al.. (2023). P117 Machine-learning derived characteristics associated with tapering TNF inhibitors in individuals with rheumatoid arthritis. Lara D. Veeken. 62(Supplement_2). 1 indexed citations

Malik, Mariam Elmegaard & Christopher Holroyd. (2023). An Update on Biosimilars in Rheumatic and Musculoskeletal Disorders. 2(1). 46–46. 1 indexed citations

Fraser, Simon, Sharon Lin, David Culliford, et al.. (2022). Persistently normal blood tests in patients taking methotrexate for RA or azathioprine for IBD: a retrospective cohort study. British Journal of General Practice. 72(720). e528–e537. 5 indexed citations

Holroyd, Christopher, Sarah Carter, Sarah Crozier, et al.. (2021). Differential relationships between parent-child DXA and pQCT bone measures: Results from the Southampton Women's Survey. Bone. 153. 116134–116134. 1 indexed citations

Wallis, Dinny, et al.. (2020). Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?. BMC Musculoskeletal Disorders. 21(1). 209–209. 6 indexed citations

Lwin, May Nwe, et al.. (2020). Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review. Rheumatology and Therapy. 7(3). 457–471. 112 indexed citations

Price, Elizabeth, Lesley Kay, Peter Lanyon, et al.. (2020). Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic. Clinical Medicine. 20(3). 256–261. 30 indexed citations

Holroyd, Christopher, Rakhi Seth, Marwan Bukhari, et al.. (2018). The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Lara D. Veeken. 58(2). e3–e42. 109 indexed citations

Holroyd, Christopher, et al.. (2017). AB0377 Switching from bio-original etanercept to biosimilar etanercept sb4: patient acceptability and outcomes in the real world. Annals of the Rheumatic Diseases. 76. 1180–1180. 12 indexed citations

10.

Holroyd, Christopher, et al.. (2016). Are there dangers in biologic dose reduction strategies?. Autoimmunity Reviews. 15(7). 742–746. 5 indexed citations

11.

Holroyd, Christopher, Brittany I Davidson, Sarah Bennett, et al.. (2013). A Strategy For Selecting Individuals With RA For Reduction Of Anti-TNF Therapy Using Combined Clinical and Ultrasound Assessment. Oxford University Research Archive (ORA) (University of Oxford). 65. 2 indexed citations

12.

Holroyd, Christopher, Nicholas C. Harvey, Sarah Crozier, et al.. (2012). Placental size at 19 weeks predicts offspring bone mass at birth: Findings from the Southampton Women's Survey. Placenta. 33(8). 623–629. 19 indexed citations

13.

Holroyd, Christopher, Cyrus Cooper, & Nicholas C. Harvey. (2011). Vitamin D and the postmenopausal population. Menopause international. 17(3). 102–107. 2 indexed citations

14.

Holroyd, Christopher, Nicholas C. Harvey, Elaine Dennison, & Cyrus Cooper. (2011). Epigenetic influences in the developmental origins of osteoporosis. Osteoporosis International. 23(2). 401–410. 79 indexed citations

15.

Holroyd, Christopher, Justin H. Davies, P Taylor, et al.. (2010). Reduced cortical bone density with normal trabecular bone density in girls with Turner syndrome. Osteoporosis International. 21(12). 2093–2099. 44 indexed citations

16.

Cole, Zoe, et al.. (2009). Session 2: Other diseases Dietary management of osteoporosis throughout the life course. Proceedings of The Nutrition Society. 69(1). 25–33. 7 indexed citations

17.

Holroyd, Christopher & Christopher J Edwards. (2009). The effects of hormone replacement therapy on autoimmune disease: rheumatoid arthritis and systemic lupus erythematosus. Climacteric. 12(5). 378–386. 39 indexed citations

18.

Holroyd, Christopher, et al.. (2007). Lung cancer mortality at a UK tin smelter. Occupational Medicine. 57(4). 238–245. 33 indexed citations

19.

Binks, K., Richard Doll, Michael Gillies, et al.. (2005). Mortality experience of male workers at a UK tin smelter. Occupational Medicine. 55(3). 215–226. 25 indexed citations

20.

Holroyd, Christopher, et al.. (2001). The use of the fluorescein disappearance test in the management of childhood epiphora. Orbit. 20(3). 181–187. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact